SARS-CoV-2 vaccine
SARS-CoV-2 vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
SARS-CoV-2 vaccine is an adjuvanted recombinant protein-based COVID-19 vaccine candidate being developed collaboratively by GlaxoSmithKline (GSK) and Sanofi. This vaccine candidate is composed of a spike protein antigen which aims to stimulate immune system production of antibodies against SARS-CoV-2; it uses technology previously employed for a recombinant influenza vaccine.
| Trade Name | SARS-CoV-2 vaccine |
| Generic | SARS-CoV-2 vaccine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here SARS-CoV-2 vaccine
